High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer
Clinical trial NCT01896271 · COMPLETED
Trial details
- NCT number
- NCT01896271
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-02
- Primary completion
- 2020-08-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.